Method·October 19, 2026 · 4 min read

Exempt from registration. Not from 510(k).

21 CFR 807.65(d) exempts a licensed practitioner from registering an establishment when a device is made solely for their own practice, under Section 510(g) of the FD&C Act. Section 510(k), the premarket notification duty, sits in the same section of the same statute and answers a different question entirely.

By Connor Griggs — Regulatory & Quality Strategist

A physician who builds or alters a device solely for their own patients, in their own practice, reads 21 CFR 807.65(d) and finds the word they were looking for: exempt. It is easy to stop reading there. The exemption that paragraph grants is real, and it is also narrower than the word suggests, because it answers one question FDA asks of a device, not all of them.

What Section 510(g) actually covers

Section 510 of the FD&C Act is titled, in full, “Registration of producers of drugs or devices,” and Section 510(g), at 21 U.S.C. § 360(g), carves out the classes of persons who don’t have to do that registering. FDA’s implementing regulation, 21 CFR 807.65, lists them one at a time: raw-material suppliers, pharmacies and retail outlets, and, at paragraph (d), “licensed practitioners, including physicians, dentists, and optometrists, who manufacture or otherwise alter devices solely for use in their practice.” FDA’s own device registration guidance spells out the boundary in practice: the exemption covers a device built for the practitioner’s own patients, and it stops the moment that practitioner starts distributing the same device to other practitioners.

The exemption has its own geographic limit too: the regulation’s lead-in restricts paragraphs (d), (e), (f), and (i) to persons located in a State as the Act defines that term, so a licensed practitioner operating entirely outside the United States and its territories doesn’t get it.

A different letter, a different duty

Section 510(k), 21 U.S.C. § 360(k), sits inside the same section of the same statute, under the same title about registration. It has nothing to do with registering an establishment. It is the premarket notification duty: before introducing a device into interstate commerce, the person responsible has to notify FDA and, ordinarily, clear the review FDA runs in response. Nothing in 807.65(d)’s text, and nothing in 510(g) itself, touches that duty at all. An exemption written into one letter of Section 510 does not travel to a different letter of the same section just because the two letters share a number.

A practitioner exempt under 510(g) has answered whether they have to register. Whether the device they built needed a 510(k) is a question 510(g) was never asked.

Where an actual exemption from review has to come from

If a practitioner-made device is also going to skip premarket notification, that exemption has to come from somewhere that actually reaches 510(k) — most commonly the custom device exemption at FD&C Act § 520(b), defined at 21 CFR 812.3(b): a device that necessarily deviates from a generally available one to meet an individual patient’s named order, capped at five units of that device type a year, with its own annual notice to FDA. That exemption is specific, conditional, and unrelated to whether the practitioner also registers an establishment. A device can fail every condition of 812.3(b) and still have been made by a practitioner who is, correctly, exempt from registering under 807.65(d) — and owe FDA a 510(k) regardless.

The practice

Reading “exempt” next to a citation is not the same as reading which duty the citation exempts. 807.65(d) answers a registration question; it was never written to answer a premarket-review question, and nothing about one exemption’s existence implies the other. Whether a specific device actually needs a 510(k), a PMA, or qualifies for its own separate exemption is a determination for the regulatory professionals who own that device — this describes how the statute is built, regulatory intelligence and method, never advice about a specific device.

It also describes a blind spot built into any record search. Per what we monitor and how often, FDA Radar’s five feeds start from events that generate a public record: a clearance, a classification, a letter, a recall. A device made under 807.65(d) alone, with no 510(k) filed because none was thought to be owed, leaves nothing in any of them to find; a device that filed the 510(k) its maker actually needed shows up exactly where it should. The two devices can come from the same kind of practitioner, and only one of them is missing from the record for a reason the record itself will never flag.

Practice
A provider letter doesn't need a recall
Method
A qualified tool has a context, not a blanket
Practice
The eMDR account isn't automatic
Method
The manufacturer who owns no factory
Practice
GLP covers the safety study, not the device
Method
Part 11 governs the copy, not the duty.
Method
A K-number isn't always a 510(k)
Practice
Approved once. Reported every year.
Method
The goal date passes. FDA owes a letter.
Method
The money a 510(k) never has to mention
Method
A discussion paper isn't guidance
Practice
A stereotaxic system isn't a RASD
Method
The A-list is a forecast, not a deadline.
Practice
Ultra has a gram range. Fragrance doesn't.
Method
Patient preference just reached the 510(k)
Practice
The health hazard evaluation isn't the record
Method
The sponsor proposes risk. The IRB decides.
Practice
A Special 510(k) needs a predicate you own
Method
The flag marks the reviewer, not the result
Practice
Call it fifteen. File it in thirty.
Method
The recognition number isn't the list number
Practice
The letter to file isn't in the guidance
Method
The PMA preempts. The 510(k) doesn't.
Practice
Cleared doesn't code. Coded doesn't cover.
Practice
Exempt from 510(k). Restricted anyway.
Method
Right to try reaches drugs, not devices
Practice
The 510(k) clears the range, not the fit
Practice
The hospital's duty runs to the maker, not FDA.
Method
The predicate study isn't the waiver study.
Method
No clinical hold for an IDE. Only disapproval.
Practice
A CFG can cover a device that never came here.
Method
The symbol skips text. The glossary can't.
Practice
The label clears 812.5. The flyer doesn't.
Method
A 510(k) can change hands. No rule says how.
Practice
A missed renewal is two violations, not one
Method
Drugs expire by rule. Devices by choice.
Practice
Denied the petition. Not the outcome.
Practice
Starting a committee is public. Renewing isn't.
Method
A recall closes. A radiation refund doesn't.
Method
The trial is public. The IDE isn't.
Practice
A PMA withdrawal pays back. A 510(k) doesn't.
Method
Interoperable is a design term, not a class.
Practice
The category is new. The 510(k) record isn't.
Practice
The device is cleared. Not the room.
Method
Classified in 2011. Excluded in 2016.
Practice
The law reached devices. The guidance hasn't.
Method
The label says RUO. FDA reads intent.
Method
Humanitarian. Not always nonprofit.
Practice
The certification has a one-year tail
Method
The code changed. The failure didn't.
Practice
Skip has a ceiling. Search after doesn't.
Method
Reviewed together. Decided separately.
Practice
Class III. Not called for PMA.
Practice
The standard for the wire, not the device
Method
A reference device isn't a predicate
Practice
A predicate checklist nobody has to follow
Method
The pathway that skips the predicate
Method
A network FDA funds, not FDA runs
Practice
Panel-recommended. Not yet classified.
Method
The pilot that needed a statute
Practice
A committee no clearance ever names
Method
Never cleared here. Exported anyway.
Practice
Built for drugs. Silent on devices.
Practice
A significant decision carries its own clock
Method
The guidance that went back to draft
Method
Breakthrough crosses centers. TAP does not.
Practice
Two lists decide who reviews your 510(k)
Method
The reprocessor holds the 510(k)
Practice
The Rx symbol never reaches the record
Method
The disqualification list names no device
Practice
The summary FDA writes, not the sponsor
Practice
A missed MDR is misbranding, not a defect
Method
Two names on one registration, two jobs
Practice
A K-number is public. The other isn't.
Method
Exempt covers the type, not the use
Method
Recognized. Not published.
Practice
The supplement got eSTAR. The PMA did not.
Method
Congress ordered a guidance, not a rule
Practice
AI-enabled is a list. Not a field.
Practice
The companion diagnostic list changed its name
Method
The master file neither of you can read
Practice
The condition inside the approval order
Method
The repair FDA calls manufacturing
Method
Vacated in March. Filed in September.
Practice
Classified. Not waived.
Practice
Emergency use isn't defined in Part 812
Method
The two-year inspection clock is gone
Method
The PMA clock starts at the last module
Practice
The Q-Sub that doesn't buy you more time
Method
Lapsed and revoked end an EUA differently
Practice
A recall strategy has a grade. openFDA doesn't.
Method
A granted De Novo becomes a predicate.
Practice
Least burdensome changes the ask, not the bar.
Method
The lab is accredited. Not the device.
Practice
Breakthrough is law. STeP is a guidance.
Practice
MDSAP replaces routine. Not for-cause.
Method
No field on a 510(k) says what it treats
Method
Discretion is a policy. Exclusion is a statute.
Practice
Designated by one office. Approved by another.
Method
MedSun sits beside MAUDE, not inside it
Practice
The five-unit device never gets a K-number
Practice
Meeting the criteria isn't a tracking order
Method
The PMA clock doesn't stop at approval
Practice
The K-number doesn't track today's device
Method
A MAUDE report proves it was filed
Practice
Not every MDR starts with the manufacturer
Method
Completed. Not terminated.
Practice
The device-ban list has three entries
Method
The UDI exception has its own deadline
Method
MDUFA VI is being negotiated in public
Practice
The inspection manual changed, not the rule
Method
The count Congress had to legislate
Practice
The small-business rate isn't retroactive
Method
A detention order has no docket to read
Practice
PMA approvals moved off the Federal Register
Method
A citizen petition names names
Practice
A market withdrawal isn't a recall
Method
Not every device letter comes from CDRH
Practice
Closed on one device. Open on the rest.
Method
No IDE is confirmed until the PMA is
Practice
The remedial-action call sets the clock
Method
Jurisdiction is a letter, not a field
Practice
An address is not a footprint
Method
The final rule that isn't final yet
Practice
The special controls aren't in the record
Method
Exempt from GMP. Not from complaints.
Practice
The notify list isn't the shortage list
Method
A constraint can't be skipped. A script can.
Practice
No cron sends this. A person does.
Method
Corrected, not rewritten
Practice
Quiet is a finding, not a default
Method
The summary is public. The statement isn't.
Practice
A competitor's 513(g) leaves no trace
Practice
An empty response field proves nothing
Method
A petition is public. Its outcome isn't.
Practice
The panel is a category, not a meeting
Method
An accessory carries its own classification
Method
A TPLC report is a category, not a device
Practice
A 522 order is a question, not a verdict
Method
A PCCP change leaves no new record
Practice
Not every signal becomes a recall
Method
eSTAR did not remove the acceptance check
Practice
An early alert has no recall number yet
Practice
A consent decree isn't a database row
Method
The record has no cybersecurity field
Practice
Classification Change is not one event
Method
Publication date is not effective date
Method
One event. Many recall numbers.
Practice
Quantity is a sentence, not a number
Practice
How a firm told you is a field too
Method
A RIN outlives the document number
Method
The docket ID is not the comments
Practice
The 510(k) record doesn't name the predicate
Practice
The 510(k) FDA didn't review first
Method
The letter FDA doesn't have to post
Practice
Cleared doesn't say which track it took
Method
The clock stops. The calendar doesn't.
Method
Why a guessed match never reaches you
Practice
The standards list never names a device
Method
The guidance isn't in the Federal Register.
Practice
Filtered. Not discarded.
Method
There are two recall databases, not one
Practice
Breakthrough status is confidential by law
Practice
One MAUDE report is not one malfunction
Method
A supplement number is not a track
Method
Cleared is not approved
Practice
Nationwide doesn't mean your building
Practice
Not every correction reaches FDA
Method
Registered. Not reviewed.
Method
Contact ODE is not a pathway
Practice
Almost no recall is FDA-mandated
Method
FDA's device names read like a card catalog
Practice
openFDA is free. It is not unlimited.
Method
GUDID stores the model. Not the box.
Practice
Detention doesn't need a warning letter
Method
A Class I device, a Class I recall
Practice
21 CFR 820 didn't move. Its contents did.
Method
The product code that doesn't exist yet
Practice
The classification posts. The 483 behind it doesn't.
Method
A recall has three dates, and the pipeline had to pick one
Practice
The count is real. The rate is not.
Method
The firm on the record is not the firm on the box
Practice
Low confidence is an instruction, not a hedge
Method
The same company, spelled three ways
Practice
A device that was never a medical device
Method
FDA's warning letters, addressed by column number
Practice
Your regulation has a decimal. FDA's watch doesn't.
Method
Three letters is too short to search for
Practice
Most warning letters never close
Method
The guidance that skipped the draft
Practice
Ongoing, as of when?
Method
The least interesting fact in a 510(k)
Practice
No recall arrives with a product code attached
Practice
The deadline that doesn't email you
Method
The warning letter has two dates
Method
How to monitor FDA without drowning
Practice
Your predicate was recalled. Now what?
Method
Why no item reaches you without a human